drugset / Trial / NCT00043095

BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors

NCT00043095

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combining BMS-247550 with gemcitabine in treating patients who have advanced solid tumors.

Timeline

Start
2002-06
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule Intravenous
Background Ixabepilone Small molecule